Sector: Healthcare | Industry: Healthcare Facilities & Services |
Company Contact | |
Address: | 1411 Broadway 16Th Floor, 137 Lewis Wharf NEW YORK NY 10018 |
Tel: | N/A |
Website: | https://www.awholdings.com |
IR: | See website |
Key People | ||
Abner Kurtin Executive Chairman of the Board | John Hartmann Chief Executive Officer, Director | Mark Cassebaum Chief Financial Officer |
Chris Holzer Chief of Operations | Robin Debiase Chief People Officer | Denise E. Pedulla Chief Legal Officer and Corporate Secretary |
Business Overview |
Ascend Wellness Holdings, Inc. is a vertically integrated multi-state cannabis operator. The Company is focused on operating in adult-use or near-term adult-use states in primarily limited license markets. It is engaged in cultivation, manufacturing, and distribution of cannabis consumer packaged goods, which are sold through Company-owned retail stores and to third-party licensed retail cannabis stores. The Company has licenses and assets in Illinois, Massachusetts, Maryland, Michigan, New Jersey, Ohio, and Pennsylvania. It produces and distributes its in-house Common Goods, Simply Herb, Ozone, Ozone Reserve, Royale, and Tunnel Vision branded products. The Company operates cultivation facilities in six states with approximately 245,000 square feet of total canopy. Common Goods is a no-frills brand that offers high value cannabis for everyday consumption. The brand comes in flower and pre-rolls. Ozone Reserve comes in exotic flower, refined concentrates, purified oils, and vapes. |
Financial Overview |
For the three months ended 31 March 2024, Ascend Wellness Holdings Inc revenues increased 25% to $142.4M. Net loss decreased 2% to $18.2M. Revenues reflect Wholesale revenue segment increase of 35% to $79M, Retail revenue segment increase of 15% to $95.2M. Lower net loss reflects Interest expense - Balancing value decrease of 5% to $8.5M (expense), Other, net increase of 17% to $310K (income). |
Employees: | 2,300 as of Dec 31, 2023 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | $514.88M as of Mar 31, 2024 |
Annual revenue (TTM): | $546.82M as of Mar 31, 2024 |
EBITDA (TTM): | $52.33M as of Mar 31, 2024 |
Net annual income (TTM): | -$47.91M as of Mar 31, 2024 |
Free cash flow (TTM): | $23.56M as of Mar 31, 2024 |
Net Debt Last Fiscal Year: | $237.61M as of Mar 31, 2024 |
Shares outstanding: | 212,726,663 as of May 6, 2024 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |